Methotrexate Tablet 2.5 mg, 10 mg, 25 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 2.5 mg, 10 mg, 25 mg
Reference Brands: Trexall (US)
Category: Arthritis
Methotrexate tablets inhibit dihydrofolate reductase, disrupting DNA synthesis and cell reproduction. It reduces inflammation and immune activity, making it effective for rheumatoid arthritis, psoriasis, and certain cancers. Benefits include disease modulation, improved joint function, rapid onset, and versatility, with a well-established safety profile when properly monitored.
Product Description:
Methotrexate tablets are approved in the EU and US for treating rheumatoid arthritis, psoriasis, and certain cancers. In the EU, Pfizer’s Trexall and generic versions are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, registration, and compliance, visit PharmaTradz. We facilitate efficient market access for methotrexate tablets, ensuring adherence to European and American standards for safe, effective autoimmune and oncological therapy.
Methotrexate Tablet — third party manufacturing & bulk supply
Methotrexate Tablet 2.5 mg, 10 mg, 25 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Methotrexate Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Methotrexate Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Methotrexate Tablet →Frequently Asked Questions
Methotrexate Tablet is used to treat certain types of cancer, severe psoriasis, and rheumatoid arthritis. It works by interfering with the growth of rapidly dividing cells, such as cancer cells, and by suppressing the immune system to reduce inflammation in autoimmune conditions.
Methotrexate Tablet contains the active ingredient methotrexate, a folate antagonist that inhibits the enzyme dihydrofolate reductase. This inhibition prevents DNA synthesis and cell replication, making it effective in slowing or stopping the growth of abnormal cells.
The trade names for Methotrexate include Trexall, Rheumatrex, and Methoblastin, depending on the country and manufacturer.
Methotrexate Tablets are manufactured by several pharmaceutical companies, including Pfizer, Teva Pharmaceuticals, and Sandoz.
The generic name of this product is Methotrexate.
The brand names of Methotrexate include Trexall, Rheumatrex, and Methoblastin.
Methotrexate Tablets are manufactured in multiple countries, including the United States, Germany, and India, by companies such as Pfizer, Teva, and Sandoz, depending on regional market supply.
Related Products
Methotrexate Injectable
Strength:
25 mg/mL, 50 mg/mL, 250 mg/10 mL vial
Form: Injectable (IV, IM, Subcutaneous)
Reference Brands: Trexall (US)
View DetailsSulfasalazine Tablets
Strength:
500 mg, 1000 mg
Form: Tablets
Reference Brands: Azulfidine(US)
View DetailsLeflunomide Tablets
Strength:
10 mg, 20 mg
Form: Tablets
Reference Brands: Arava(US & EU)
View DetailsHydroxychloroquine Tablets
Strength:
200 mg
Form: Tablets
Reference Brands: Plaquenil(US & EU)
View DetailsAceclofenac Injection
Strength:
150 mg/ml
Form: Injection
Reference Brands: Various Indian Brand
View DetailsDiacerein, Glucosamine Sulphate & Methyl Sulfonyl Methane Tablets
Strength:
10 Tab
Form: Tablets
Reference Brands: Dona (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers